These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15198462)

  • 1. Second-generation antipsychotics: looking beyond efficacy.
    Awad AG
    Can J Psychiatry; 2004 May; 49(5):283-4. PubMed ID: 15198462
    [No Abstract]   [Full Text] [Related]  

  • 2. First- and second-generation antipsychotics: learning from CUtLASS and CATIE.
    Tandon R; Carpenter WT; Davis JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):977-8; author reply 979-80. PubMed ID: 17679642
    [No Abstract]   [Full Text] [Related]  

  • 3. New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?
    Awad AG; Voruganti LN
    Can J Psychiatry; 2004 May; 49(5):297-302. PubMed ID: 15198465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From neuroleptics toward antipsychotics: quality of life and schizophrenia].
    Lançon C
    Encephale; 2003 Sep; 29(Pt 2):S43-6. PubMed ID: 14710537
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic-induced deficit syndrome (NIDS).
    J Clin Psychiatry; 1993 Dec; 54(12):493-500. PubMed ID: 7903967
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.
    Tandon R; Belmaker RH; Gattaz WF; Lopez-Ibor JJ; Okasha A; Singh B; Stein DJ; Olie JP; Fleischhacker WW; Moeller HJ;
    Schizophr Res; 2008 Mar; 100(1-3):20-38. PubMed ID: 18243663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of schizophrenia drugs: a focus on dopaminergic systems.
    Nikam SS; Awasthi AK
    Curr Opin Investig Drugs; 2008 Jan; 9(1):37-46. PubMed ID: 18183530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric disorders: The choice of antipsychotics in schizophrenia.
    Margolis RL
    Nat Rev Neurol; 2009 Jun; 5(6):308-10. PubMed ID: 19498434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.
    Conley RR; Kelly DL
    Isr J Psychiatry Relat Sci; 2005; 42(1):51-60. PubMed ID: 16134407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.
    Vohora D
    Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First- and second-generation antipsychotics.
    McEvoy JP; Zigman D; Margolese HC
    Can J Psychiatry; 2010 Mar; 55(3):144-8; discussion 148-9. PubMed ID: 20370964
    [No Abstract]   [Full Text] [Related]  

  • 13. Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?
    Motlová L; Spaniel F; Höschl C; Balon R
    Ann Clin Psychiatry; 2007; 19(2):133-43. PubMed ID: 17612853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective experiences on antipsychotic medications: synthesis and conclusions.
    Marder SR
    Acta Psychiatr Scand Suppl; 2005; (427):43-6. PubMed ID: 15877721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.
    Miyamoto S; Duncan GE; Marx CE; Lieberman JA
    Mol Psychiatry; 2005 Jan; 10(1):79-104. PubMed ID: 15289815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychotics.
    Kilian R; Dietrich S; Toumi M; Angermeyer MC
    Acta Psychiatr Scand; 2004 Aug; 110(2):108-18. PubMed ID: 15233711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacology and clinical implication of typical antipsychotics].
    Ohmori T
    Nihon Rinsho; 2013 Apr; 71(4):648-53. PubMed ID: 23678594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia treatment. Critical review on the drugs and mechanisms of action of antipsychotics.
    Tajima K; Fernández H; López-Ibor JL; Carrasco JL; Díaz-Marsá M
    Actas Esp Psiquiatr; 2009; 37(6):330-42. PubMed ID: 20066585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarities and differences among antipsychotics.
    Tamminga CA
    J Clin Psychiatry; 2003; 64 Suppl 17():7-10. PubMed ID: 14680420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.